Methenamine Mandelate for Oral Solution
» Methenamine Mandelate for Oral Solution contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of methenamine mandelate (C6H12N4·C8H8O3).
Packaging and storage—
Preserve in well-closed containers.
Labeling—
Label Methenamine Mandelate for Oral Solution that contains insoluble ingredients to indicate that the aqueous constituted Oral Solution contains dissolved methenamine mandelate, but may remain turbid because of the presence of added substances.
Identification—
A finely powdered portion, equivalent to about 100 mg of methenamine mandelate, responds to the Identification test under Methenamine Mandelate Oral Suspension.
Uniformity of dosage units 
905
—
905—
for powder packaged in single-unit containers:
meets the requirements.
Deliverable volume 698
698
for powder packaged in multiple-unit containers:
meets the requirements.
pH 791:
between 4.0 and 4.5, in a mixture of 1 g with 30 mL of water.
791:
between 4.0 and 4.5, in a mixture of 1 g with 30 mL of water.
Water, Method I 921:
not more than 0.5%.
921:
not more than 0.5%.
Assay—
Accurately weigh the contents of not fewer than 10 containers of Methenamine Mandelate for Oral Solution, and reduce to a fine powder. Transfer an accurately weighed portion of the powder, equivalent to about 60 mg of methenamine mandelate, to a 150-mL beaker. Add 15 mL of dehydrated alcohol, stir to dissolve, and proceed as directed in the Assay under Methenamine Mandelate, beginning with “add 40 mL of chloroform.”
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
| Monograph | Behnam Davani, Ph.D., M.B.A.
Senior Scientist 1-301-816-8394 |
(MDAA05) Monograph Development-Antivirals and Antimicrobials |
| Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |
USP32–NF27 Page 2923
Pharmacopeial Forum: Volume No. 29(6) Page 1930